NO MORE SYRINGES, NO MORE MIXING, ON-THE-GO EASE OF USE, SIMPLE ADJUSTABLE DOSING. Simply twist the pre-set dosing wheel to your desired/reccomended dose, apply the top, and simply administer into the skin.
Manufacturer: ZPHC (ZPHC Pharmaceutical Co. Ltd) Non-Generic
Active Ingredient: Tirzepatide
Concentration: 30mg per pen
Volume: 1
Form: Aqua Integrated Cartridge
Purpose: Diabetes management, weight loss
Action: Tirzepatide helps regulate blood sugar levels and reduce appetite, mimicking the effects of natural incretin hormones. This aids in better glycemic control and promotes weight reduction.
Administration Route: Subcutaneous injections after reconstitution
Recommended Dosage: Prescribed by a healthcare professional
Side Effects: Possible side effects include nausea, diarrhea, decreased appetite, and potential allergic reactions
Storage: Store in a cool, dry place, protected from light. Refrigerate after reconstitution
Tirzepatide 30mg ZPHC is a revolutionary compound with a simple Pen application, designed for research purposes only. As a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, Tirzepatide offers a unique mechanism of action that enhances insulin secretion, reduces appetite, and promotes satiety. This multifaceted approach makes it an intriguing subject of study for its potential effects on type 2 diabetes and obesity, helping to improve glycemic control and facilitate significant weight reduction.
Manufactured to the highest quality standards, Tirzepatide 30mg Pen by ZPHC ensures reliability and consistency in every dose, providing researchers with a dependable product for their studies. While its benefits extend beyond blood sugar management and weight loss, including cardiovascular protection and improved metabolic health, it is important to note that Tirzepatide is strictly for research use only and not intended for human consumption. Always handle with care and follow all applicable safety guidelines when conducting research.